Calloe Kirstine, Di Diego José M, Hansen Rie Schultz, Nagle Shea A, Treat Jacqueline A, Cordeiro Jonathan M
Danish National Research Foundation Center for Cardiac Arrhythmias, Department of Veterinary Clinical and Animal Science, University of Copenhagen, DK-1870 Frederiksberg C, Denmark.
Department of Experimental Cardiology, Masonic Medical Research Laboratory, Utica, NY 13501, USA.
Biochem Pharmacol. 2016 May 15;108:36-46. doi: 10.1016/j.bcp.2016.03.015. Epub 2016 Mar 19.
A loss of repolarization reserve due to downregulation of K(+) currents has been observed in cultured ventricular myocytes. A similar reduction of K(+) currents is well documented under numerous pathophysiological conditions. We examined the extent of K(+) current downregulation in cultured canine cardiac myocytes and determined whether a dual K(+) current activator can normalize K(+) currents and restore action potential (AP) configuration.
Ventricular myocytes were isolated and cultured for up to 48 h. Current and voltage clamp recordings were made using patch electrodes. Application of NS3623 to coronary-perfused left ventricular wedges resulted in increased phase 1 magnitude, epicardial AP notch and J wave amplitude. Patch clamp measurements of IKr and Ito revealed an increase in the magnitude of both currents. Culturing of Mid ventricular cells resulted in a significant decrease in Ito and IKr density. NS3623 increased Ito from 16.4 ± 2.23 to 31.8 ± 4.5 pA/pF, and IKr from 0.28 ± 0.06 to 0.47 ± 0.09 pA/pF after 2 days in culture. AP recordings from 2 day cultured cells exhibited a reduced phase 1 repolarization, AP prolongation, and early afterdepolarizations (EADs). NS3623 restored the AP notch and was able to suppress EADs.
NS3623 is a dual Ito and IKr activator. Application of this compound to cells with a reduced repolarization reserve resulted in an increase in these currents and a shortening of AP duration, increase in phase 1 repolarization and suppression of EADs. Our results suggest a potential benefit of K(+) current activators under conditions of reduced repolarization reserve including heart failure.
在培养的心室肌细胞中已观察到由于钾离子电流下调导致的复极储备丧失。在众多病理生理条件下,钾离子电流的类似减少也有充分记录。我们研究了培养的犬心肌细胞中钾离子电流下调的程度,并确定双钾离子电流激活剂是否能使钾离子电流正常化并恢复动作电位(AP)形态。
分离心室肌细胞并培养长达48小时。使用膜片电极进行电流和电压钳记录。将NS3623应用于冠状动脉灌注的左心室楔形组织,导致1期幅度增加、心外膜AP切迹和J波幅度增加。对IKr和Ito的膜片钳测量显示这两种电流的幅度均增加。培养中层心室细胞导致Ito和IKr密度显著降低。培养2天后,NS3623使Ito从16.4±2.23增加到31.8±4.5 pA/pF,IKr从0.28±0.06增加到0.47±0.09 pA/pF。对培养2天的细胞进行AP记录显示1期复极化减少、AP延长和早期后去极化(EADs)。NS3623恢复了AP切迹并能够抑制EADs。
NS3623是一种双Ito和IKr激活剂。将该化合物应用于复极储备降低的细胞导致这些电流增加、AP持续时间缩短、1期复极化增加和EADs抑制。我们的结果表明,在包括心力衰竭在内的复极储备降低的情况下,钾离子电流激活剂具有潜在益处。